Cardiac Assist Devices Market Outlook (2023 to 2033)

The global cardiac assist devices market is poised to surpass US$ 1.37 billion by 2023, surging at a remarkable CAGR of 6.1% through 2033 to reach US$ 2.48 billion.

The incorporation of advanced technology such as the Internet of Thinking and rising investment from leading players results in market growth.

The technologies utilized to create cardiac devices have advanced dramatically during the past ten years, and so have the indications for these devices. Due to this, many patients are now being handled with cardiology devices, which have had exponential therapeutic and monitoring outcomes.

The development that has had a big positive effect on cardiology is artificial intelligence, which has increased diagnostic skills for some cardiac disorders.

Attributes Details
Cardiac Assist Devices Market Estimated Value (2023) US$ 1.37 billion
Cardiac Assist Devices Market Estimated Value (2033) US$ 2.48 billion
Cardiac Assist Devices Market Value CAGR (2023 to 2033) 6.1% CAGR

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

2018 to 2022 Global Cardiac Assist Devices Market Outlook in Comparison to 2023 to 2033 Forecast

Cardiac Assist Devices Market recorded steady growth of 5.8% CAGR during the historical period, from 2018 to 2022. The rising prevalence of heart failure across the globe resulted in increased demand for cardiac assist devices.

Technological development in the field of ventricular assist devices is recognized as a key driver for the growth of the cardiac assist devices industry with mounting cases of coronary heart diseases.

As per FMI’s analysis, growth in cardiac assist devices is attributed to the increasing prevalence of lifestyle disorders that are the main cause of cardiovascular diseases. Cardiovascular diseases such as coronary heart disease and others have led to increased cases of heart failure, especially across the United States of America, the United Kingdom, and India.

Demand for heart transplantation has significantly increased due to the rising cases of heart failure. However, the unavailability of heart donors and long waiting list result in increased mortality rates.

Patients are hence opting for ventricular assist devices for the treatment of heart failure. Due to the increased demand for ventricular assist devices, leading companies are continuously developing advanced cardiac assist devices catering to the demand. Moreover, key companies are adopting cutting-edge technologies such as artificial intelligence and the Internet of Thinking to facilitate the rising demand and curb mortality rates.

As per FMI, the market witnessed a year-on-year (Y-o-Y) growth at 6.1% CAGR, topping US$ 2.48 billion in 2033.

What is the Impact of Demand for Minimally Invasive Devices on the Market?

  • Integration of cutting-edge technologies such as artificial intelligence and the Internet of Things has led to technological advancements in cardiac assist devices, propelling an increase in demand.
  • The growing presence of robots and automated devices in operating rooms has created a need for minimally invasive devices, resulting in a surge in sales of cardiac assist devices.
  • State-of-the-art technologies and a rising number of patients preferring non-invasive devices have contributed to the increased demand for implantable devices. Benefits such as fast recovery and short hospital stays are driving the demand for non-invasive options.
  • The soaring demand has prompted key players to engage in research and development activities, focusing on innovation in cardiac assist devices.
  • Market players are particularly focused on developing small centrifugal pumps that enable less-invasive implantation procedures.
  • The adoption of minimally invasive techniques in cardiac procedures has led to a shift in the market landscape, with an emphasis on developing and improving technologies that enable less invasive interventions.
  • The demand for minimally invasive devices has led to improved patient outcomes, including short recovery times, reduced hospital stays, and few post-operative complications.
  • The increasing demand for minimally invasive devices is expected to continue driving market growth and expand treatment options for patients requiring cardiac assist devices.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

How are the High Cost and Risk Associated with Ventricular Assist Devices Expected to Restrict Growth?

  • The high cost and associated risks of ventricular assist devices pose a restriction on market growth.
  • Patients in developing economies, such as Africa and India, are unable to afford the cost of these devices, limiting their accessibility.
  • While healthcare professionals highly recommend ventricular assist devices, risks such as pump thrombus, suction events, and infections present challenges for market players.
  • After the implantation of left ventricular assist devices (LVAD), around 60% of patients experience complications within 6 months, and 80% suffer from at least one adverse effect after a year, as reported by the European Society of Cardiology.
  • Unplanned hospital revisits are common for patients who have undergone LVAD transplantation, further highlighting the challenges and risks associated with these devices.
  • The risks represent potential threats for market players and are expected to hinder the demand for ventricular assist devices.

Comparative View of the Cardiac Assist Devices Market

Cardiac Assist Devices Market:

Attributes Cardiac Assist Devices Market
CAGR (2023 to 2033) 6.1%
Market Value (2033) US$ 2.48 billion
Opportunity As healthcare infrastructure improves in developing economies, there is a growing demand for advanced medical technologies, including cardiac assist devices. By entering these markets, companies can tap into new customer bases and increase their market share.
Key Trends Integration of remote monitoring and telemedicine capabilities allows healthcare providers to remotely monitor patients' cardiac function and device performance, enabling early detection of complications and timely intervention.

Cardiac Surgery Devices Market:

Attributes Cardiac Surgery Devices Market
CAGR (2023 to 2033) 3.5%
Market Value (2033) US$ 2.45 billion
Opportunity Product launches and favorable government investments are projected to be the primary growth strategies.
Key Trends One unique trend in the cardiac surgery devices market is the advancement of robotic-assisted cardiac surgery, allowing for small incisions, reduced trauma to the patient, and improved surgical outcomes.

Heart Closure Devices Market:

Attributes Heart Closure Devices Market
CAGR (2023 to 2033) 14.9%
Market Value (2033) US$ 10.88 billion
Opportunity Increasing focus on personalized medicine and customized closure solutions and the opportunity lies in the development of heart closure devices that can be customized to fit individual patient needs.
Key Trends A unique trend in the heart closure devices market is the development of bioresorbable closure devices, which presents an opportunity for manufacturers to provide innovative and patient-friendly solutions.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Insights

Why is the United States of America Likely to Remain at the Forefront of the Cardiac Assist Devices Market?

Over the past few years, the United States of America has been in the lead in terms of healthcare. Increasing cases of cardiovascular disease contributed to the country’s market share of 51.7% in 2022.

Technological advancements in the field of cardiac assist devices are one of the key factors driving growth. The rising prevalence of heart failure within the country has increased the demand for ventricular assist devices. Furthermore, healthcare professionals and scientists are incessantly working on developing next-generation ventricular assist devices.

Thanks to the presence of leading players such as Medtronic PLC., and Abbott Laboratories, the development of cardiac assist devices and new launches, have significantly improved the market revenue.

Increasing preference for non-invasive, portable, and implantable devices has also accelerated the market growth in the country. Leading healthcare companies are developing products in the pipeline focusing on minimally invasive ventricular assist devices. For instance,

  • In March 2020, the United States of America-based healthcare giant, SynCardia Systems LLC, got approval from the United States of America Food and Drug Administration (FDA) for a 50cc temporary total artificial heart system as a bridge to heart transplant for patients who are at imminent risk for death from biventricular failure.

With the rising incidence of cardiovascular disease in the country, the number of heart transplant surgeries is increasing at a mounting pace. However, the severe shortage of organ donors has resulted in increasing demand for heart devices. The increasing number of patients opting for cardiac assist devices in the United States of America fuels the market growth during the forecast period.

How does the Market in India Emerge as a Notable One for Cardiac Assist Devices?

As per Future Market Insights, India is anticipated to be one of the highly profitable markets of South Asia in the cardiac assist devices market with a projected CAGR of 5.1% from 2023 to 2033.

The expansion of the healthcare sector and the development of ventricular assist devices are affecting the market growth positively. The prevalence of heart failure in the country has resulted in increased demand for cardiac assist devices. Additionally, increased government funding and initiatives for the development of healthcare facilities are likely to boost growth across India.

India is the top country with a high diabetic population, and nearly 77 million people suffer from diabetes, estimates International Diabetes Federation. Diabetes is the primary cause of developing major heart disease. One-fifth of the Indian population succumb due to coronary heart disease.

India is witnessing a simultaneous uptick in the number of heart failure, especially among the younger population due to the rising cases of coronary heart disease. With the increasing burden of heart failure in the country, patients are opting for minimally invasive procedures. This, in turn, has increased the demand for ventricular assist devices, especially left ventricular assist devices in India.

Growing government funding and initiatives are also aiding the growth of the cardiac assist devices market. For instance, the Government of Assam Health and Family Welfare has introduced a scheme in which government bears the expenses of surgery for children with coronary heart disease.

What are the Factors Driving Revenue Generation in the United Kingdom Market?

Growth in the United Kingdom for cardiac assist devices is attributable to the increasing technological advancements in the field of ventricular assist devices, where the United Kingdom garnered a revenue share of 6.4% in 2022.

With the rising prevalence of coronary heart diseases resulting in heart failure, the adoption of ventricular assist devices is improving. Furthermore, the expansion of healthcare infrastructure and leading companies focusing on the development of next-generation cardiac assist devices have improved the adoption of ventricular assist devices.

Leading player based in the United Kingdom, Calon Cardio-Technology, for instance, intends to receive CE marking fulfilling the European products requirement for its ventricular assist device, commonly known as, MiniVAD.

Increasing investment in the development of these devices is creating incremental opportunities for cardiac assist devices in the country. With patients now opting for minimally invasive devices for the treatment of heart failure, demand for ventricular assist devices is burgeoning across the United Kingdom.

What Factors Support the Growth of Cardiac Assist Devices in Germany?

As per Future Market Insights, Germany is anticipated to lead the growth of Europe’s cardiac assist market, holding a value share of 11.2% in 2022 globally.

Technological advancements and innovation in ventricular assist devices are key growth factors driving the demand for cardiac assist devices in Germany. Moreover, companies are investing hugely in the development of cardiac assist devices to cater to the increasing demand.

Increasing initiatives and funding from the government are also aiding the growth of the cardiac assist devices market in Germany. Further, leading players such as Biotronik, are developing next-generation implantable and ventricular assist devices for patients suffering from heart failure.

  • In July 2021, BIOTRONIK’s implantable cardiac monitor received recognition as a high-performing noiseless, and high-precision technology.

Category-wise Insights

Why is the Demand for Ventricular Assist Devices (VAD) Rising?

Accounting for over 62.49% of global revenue share, ventricular assist devices are anticipated to be highly sought-after in the cardiac assist devices industry. Increasing demand for left ventricular assist devices in aiding the growth of VAD.

Future Market Insights estimates VAD to be the product of choice in the market. As healthcare professionals and engineers are developing next-generation devices fully implantable on both sides of the heart, ventricular assist devices are expected to gain traction.

Growth in this segment is attributed to technological advancements, the rising prevalence of cardiac arrest, and the shortage of organ donors. Also, advancements and upgradation in the development of LVAD have bolstered its adoption.

Leading healthcare companies such as Abbott Laboratories, Medtronic PLC, and Abiomed are increasing research activities to develop advanced LVAD catering to the rising demand. With rapid development, companies are seeking fast-track approvals from regulatory bodies which are resulting in high investment.

With the increasing demand for technologically updated ventricular assist devices, the market is expected to register high demand in the next decade.

Why are Implantable Devices Gaining Popularity in Cardiac Assist Devices Market?

Based on modality type, the market is segmented into transcutaneous and implantable cardiac assist devices. As per Future Market Insights, the implantable devices segment captured a share of 60.79% in 2022.

Owing to the benefits of the ability to screen, monitor, and control erratic heart rhythms, implantable devices are expected to gain immense popularity during the forecast period. Moreover, the rising need for efficient solutions to manage heart failure is predicted to improve the adoption of implantable devices. Additionally, increasing preference for non-invasive surgical procedures has accelerated the adoption of implantable devices.

An implantable cardioverter defibrillator is a useful device that helps prevent sudden death in patients suffering from sustained ventricular tachycardia or fibrillation. Technological advancements and gradation in implantable cardiac assist devices have improved the demand.

How are Hospital Pharmacies Gaining Popularity as the Primary End-User?

Hospital pharmacies are gaining popularity as the primary end-user in the healthcare industry due to several reasons that are contributing to the sub-segment share of 79.8% in 2022.

Firstly, hospital pharmacies offer a centralized and convenient source of medication procurement and distribution within the hospital setting. This ensures efficient inventory management, reduces medication errors, and improves patient safety.

Secondly, hospital pharmacies provide specialized pharmaceutical services, including compounding, drug information, and medication management, tailored to the unique needs of the hospital and its patients.

Lastly, with the increasing complexity of medication therapies and the need for close collaboration with healthcare providers, hospital pharmacies play a vital role in ensuring optimal patient outcomes and medication utilization.

How is the Competitive Landscape in the Cardiac Assist Devices Industry Structured?

As per FMI’s analysis, continuous innovation and gradation in cardiac assist devices have led to intense competition among top market players.

Key players are focusing on new product launches and gaining approvals from regulatory bodies to stay in the competition. Nearly 75% of the global market share is accounted for by the top 7 players operating in the cardiac assist devices market.

Organizations are also adopting winning strategies such as collaborations and mergers among key players. These strategies are also adopted by regional players to gain a leading position in the industry.

Key Players Operating in the Market

  • Terumo Corporation
  • Medtronic PLC
  • Abbott Laboratories
  • Abiomed Inc.
  • Teleflex Incorporated
  • Maquet GmbH
  • BerlinHeart GmbH
  • Others

Developments in the Market:

  • In June 2021, Abbott Laboratories announced that the company can support the expanded use of a mechanical circulatory support device, HEARTMATE 3™ Heart Pump, for the effective treatment of heart failure.
  • In February 2021, CARMAT, the leading designer and developer of the world’s most advanced artificial heart, received approval from the United States of America Food and Drugs Administration (FDA) to use the new version of its artificial heart in the US Early Feasibility Study (EFS).

Market by Category

By Product Type:

  • Ventricular Assist Devices (VAD)
    • Left Ventricular Assist Device (LVAD)
    • Right Ventricular Assist Device (RVAD)
    • Biventricular Assist Device (BIVAD)
    • External Ventricular Assist Devices
  • Intra-Aortic Balloon Pump

By Modality Type:

  • Transcutaneous
  • Implantable

By End User:

  • Hospital
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan (APEJ)
  • Japan
  • The Middle East & Africa (MEA)

Frequently Asked Questions

What is the Current Magnitude of the Cardiac Assist Devices Market?

The cardiac assist devices market value reaches US$ 1.37 billion in 2023.

What are the Projected Dimensions of the Cardiac Assist Devices Market by 2033?

The cardiac assist devices market is anticipated to surpass US$ 2.48 billion by 2033, recording a CAGR of 6.1%.

Which Category could Gain Prominence in the Modality Type Aspect of the Cardiac Assist Devices Market?

The implantable cardiac assist devices segment is likely to gain prominence, holding 60.79% of market revenue.

Which Country Holds High Lucrativeness for Cardiac Assist Devices?

The United States boasts lucrative potential for cardiac assist devices with advanced healthcare infrastructure and increasing cardiovascular conditions.

Who are the Key Cardiac Assist Devices Market Players?

Key cardiac assist devices market players are Terumo Corporation, Medtronic PLC, Abbott Laboratories, Abiomed Inc., Teleflex Incorporated, Maquet GmbH, BerlinHeart GmbH, and others.

Table of Content
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033

        5.3.1. Ventricular Assist Devices (VAD)

            5.3.1.1. Left Ventricular Assist Device (LVAD)

            5.3.1.2. Right Ventricular Assist Device (RVAD)

            5.3.1.3. Biventricular Assist Device (BIVAD)

            5.3.1.4. External Ventricular Assist Devices

        5.3.2. Intra-Aortic Balloon Pump

    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Modality Type

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Modality Type, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Modality Type, 2023 to 2033

        6.3.1. Transcutaneous

        6.3.2. Implantable

    6.4. Y-o-Y Growth Trend Analysis By Modality Type, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Modality Type, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By End-User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-User, 2023 to 2033

        7.3.1. Hospital

        7.3.2. Ambulatory Surgical Centers

    7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product Type

        9.2.3. By Modality Type

        9.2.4. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product Type

        9.3.3. By Modality Type

        9.3.4. By End-User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product Type

        10.2.3. By Modality Type

        10.2.4. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product Type

        10.3.3. By Modality Type

        10.3.4. By End-User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product Type

        11.2.3. By Modality Type

        11.2.4. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product Type

        11.3.3. By Modality Type

        11.3.4. By End-User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product Type

        12.2.3. By Modality Type

        12.2.4. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product Type

        12.3.3. By Modality Type

        12.3.4. By End-User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product Type

        13.2.3. By Modality Type

        13.2.4. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product Type

        13.3.3. By Modality Type

        13.3.4. By End-User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product Type

        14.2.3. By Modality Type

        14.2.4. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product Type

        14.3.3. By Modality Type

        14.3.4. By End-User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product Type

        15.2.3. By Modality Type

        15.2.4. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product Type

        15.3.3. By Modality Type

        15.3.4. By End-User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product Type

            16.1.2.2. By Modality Type

            16.1.2.3. By End-User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product Type

            16.2.2.2. By Modality Type

            16.2.2.3. By End-User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product Type

            16.3.2.2. By Modality Type

            16.3.2.3. By End-User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product Type

            16.4.2.2. By Modality Type

            16.4.2.3. By End-User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product Type

            16.5.2.2. By Modality Type

            16.5.2.3. By End-User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product Type

            16.6.2.2. By Modality Type

            16.6.2.3. By End-User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product Type

            16.7.2.2. By Modality Type

            16.7.2.3. By End-User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product Type

            16.8.2.2. By Modality Type

            16.8.2.3. By End-User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product Type

            16.9.2.2. By Modality Type

            16.9.2.3. By End-User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product Type

            16.10.2.2. By Modality Type

            16.10.2.3. By End-User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product Type

            16.11.2.2. By Modality Type

            16.11.2.3. By End-User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product Type

            16.12.2.2. By Modality Type

            16.12.2.3. By End-User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product Type

            16.13.2.2. By Modality Type

            16.13.2.3. By End-User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product Type

            16.14.2.2. By Modality Type

            16.14.2.3. By End-User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product Type

            16.15.2.2. By Modality Type

            16.15.2.3. By End-User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product Type

            16.16.2.2. By Modality Type

            16.16.2.3. By End-User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product Type

            16.17.2.2. By Modality Type

            16.17.2.3. By End-User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product Type

            16.18.2.2. By Modality Type

            16.18.2.3. By End-User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product Type

            16.19.2.2. By Modality Type

            16.19.2.3. By End-User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product Type

            16.20.2.2. By Modality Type

            16.20.2.3. By End-User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product Type

            16.21.2.2. By Modality Type

            16.21.2.3. By End-User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product Type

            16.22.2.2. By Modality Type

            16.22.2.3. By End-User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product Type

            16.23.2.2. By Modality Type

            16.23.2.3. By End-User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product Type

        17.3.3. By Modality Type

        17.3.4. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Terumo Corporation

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

        18.1.2. Medtronic PLC

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

        18.1.3. Abbott Laboratories

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

        18.1.4. Abiomed Inc.

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

        18.1.5. Teleflex Incorporated

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

        18.1.6. Maquet GmbH

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

        18.1.7. BerlinHeart GmbH

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

19. Assumptions & Acronyms Used

20. Research Methodology
Recommendations

Healthcare

Cardiac Surgery Devices Market

August 2017

REP-GB-4602

October 2022

320 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Cardiac Assist Devices Market